1. Home
  2. PTCT vs PAGP Comparison

PTCT vs PAGP Comparison

Compare PTCT & PAGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$63.29

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo Plains GP Holdings L.P. Units representing Limited Partner Interests

PAGP

Plains GP Holdings L.P. Units representing Limited Partner Interests

HOLD

Current Price

$26.33

Market Cap

5.6B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
PAGP
Founded
1998
2013
Country
United States
United States
Employees
991
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Natural Gas Distribution
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.6B
IPO Year
2006
2013

Fundamental Metrics

Financial Performance
Metric
PTCT
PAGP
Price
$63.29
$26.33
Analyst Decision
Buy
Buy
Analyst Count
17
10
Target Price
★ $80.65
$22.11
AVG Volume (30 Days)
918.2K
★ 1.4M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
★ 6.90%
EPS Growth
264.48
★ 370.00
EPS
★ 0.90
0.27
Revenue
$264,734,000.00
★ $44,262,000,000.00
Revenue This Year
N/A
$10.57
Revenue Next Year
$17.70
N/A
P/E Ratio
★ $69.20
$99.96
Revenue Growth
★ 36.19
N/A
52 Week Low
$58.90
$16.69
52 Week High
$90.87
$28.70

Technical Indicators

Market Signals
Indicator
PTCT
PAGP
Relative Strength Index (RSI) 34.72 36.50
Support Level N/A $22.78
Resistance Level $68.93 $26.78
Average True Range (ATR) 1.97 0.48
MACD -0.32 -0.25
Stochastic Oscillator 22.43 0.23

Price Performance

Historical Comparison
PTCT
PAGP

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About PAGP Plains GP Holdings L.P. Units representing Limited Partner Interests

Plains GP Holdings LP owns and operates midstream energy infrastructure and provides logistics services for crude oil, natural gas liquids (NGL), and natural gas. The group manages its operations through two operating segments: Crude Oil segment operations generally consist of gathering and transporting crude oil using pipelines (including gathering systems), trucks, and, at times, on barges or railcars; and NGL segment operations involve NGL storage and terminalling from NGL assets located in the Southwestern United States. It generates the majority of its revenue from the Crude Oil segment. Its geographic markets are the United States and Canada. It generates the majority of its revenue from the United States.

Share on Social Networks: